FDA approves new IV Triferic Formulation for anemia in hemodialysis patients Dr. Kamal Kant Kohli29 March 2020 11:00 PM ISTThe US Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Triferic AVANU, an intravenous formulation of an existing...
Low dose aspirin a day does not prevent dementia, finds study Hina Zahid29 March 2020 3:45 PM ISTMINNEAPOLIS - Daily low-dose aspirin intake does not reduce the risk of thinking and memory problems caused by mild cognitive impairment or probable...
Breaking news: USFDA approves Point-of-Care Test that can detect Novel Coronavirus in 5 mins Hina Zahid28 March 2020 11:21 AM ISTUSA: The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to Abbott's molecular point-of-care test can detect...
Majority of legal marijuana products too strong for pain relief Dr. Kamal Kant Kohli28 March 2020 10:15 AM ISTA new analysis suggests that some forms of medical marijuana may be stronger than necessary for pain management.
Convalescent plasma administration may improve outcomes in Covid 19 patients Dr. Kamal Kant Kohli28 March 2020 9:35 AM ISTIn a small study preliminary findings raise the possibility that convalescent plasma transfusion may be helpful in the treatment of critically ill...
Chloroquine in Covid 19- Beware of cardiac risk in unapproved indications Dr. Kamal Kant Kohli27 March 2020 7:45 PM ISTNEW ORLEANS/ -- The current COVID-19 pandemic has impacted economic and social aspects of society around the globe.According to a letter published in...
FDA grants emergency authorisation to another Covid 19 test Dr. Kamal Kant Kohli27 March 2020 7:00 PM ISTBGI's test now has global approvals through US FDA, Europe's CE-IVD, and China's NMPA Kits are currently being distributed to more than 70 countries...
EMA grants marketing authorisation for Cenobamate for treating Focal Seizures in Adults Dr. Kamal Kant Kohli27 March 2020 6:45 PM ISTPANGYO - European Medicines Agency (EMA) has accepted Arvelle Therapeutics' Marketing Authorization Application (MAA) for cenobamate, an...
Phase III clinical trial of chikungunya vaccine launched by Valneva Dr. Kamal Kant Kohli27 March 2020 6:30 PM ISTThe US Food and Drug Administration (FDA) and French biotech company Valneva have agreed on VLA1553's clinical development plan.The company is all...
Too much salt not only raises BP, may weaken immune system also Hina Zahid27 March 2020 6:30 PM ISTDiet is rich in salt poses various health risks. A high-salt diet (HSD) can elevate blood pressure and alongside increase vulnerability to bacteria...
New drug receives Orphan Drug Designation for Phenylketonuria treatment from FDA Dr. Kamal Kant Kohli27 March 2020 5:15 PM ISTBALERNA - The US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for the Company's drug candidate APR-OD031 for the...
Revolutionary breathing device offers likely solution to COVID-19 pandemic Dr. Kamal Kant Kohli27 March 2020 11:30 AM ISTHARTFORD, Conn. -- Medi-Immune, Ltd., have today revealed ProtectivAir®, a breathing device which has proven effective against viral and bacterial...
